Katie Cordes Darden

Jul 17, 2024 | jdsupra.com | David Cox |Katie Cordes Darden |Delaney Durst

Deal volume across the healthcare industry generally appears to have steadied despite headwinds.

Jul 17, 2024 | mondaq.com | David Cox |Katie Cordes Darden |Delaney Durst |Ben Kelly

Deal volume across the healthcare industry generally appears to have steadied despite headwinds. The general sentiment is that buyers have adapted to the current interest rates and are gritting their teeth and pressing forward—especially private equity (PE) investors who need to deploy their "dry powder." Continued Private Equity Backlash As detailed in previous reports, PE's investment in healthcare has seen increased regulatory scrutiny at both the state and federal levels.